Literature DB >> 21617875

Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations.

Ewa Wybieralska1, Katarzyna Szpak, Andrzej Górecki, Piotr Bonarek, Katarzyna Miękus, Justyna Drukała, Marcin Majka, Krzysztof Reiss, Zbigniew Madeja, Jarosław Czyż.   

Abstract

In the present study, we investigated the effects of fenofibrate on the invasive potential of DU-145 human prostate cancer cells in the context of gap junctional intercellular coupling and the formation of reactive oxygen species. Time-lapse analyses of cell motility, accompanied by tests of cell viability, membrane microviscosity, reactive oxygen species accumulation and the function of gap junctional protein connexin 43 were performed in monolayer cultures of DU-145 cells following fenofibrate administration. Fenofibrate inhibited the motility of DU-145 cells and attenuated gap junctional intercellular coupling in a manner independent of its effects on cell viability, PPARα activation and cell membrane micro-viscosity. Instead, N-acetyl-L-cysteine, a scavenger of reactive oxygen species, restored cell motility and gap junctional coupling in fenofibrate-treated DU-145 cell populations. These data indicate that two parameters crucial for cancer cell metastatic potential, i.e. cell motility and gap junctional coupling, are inhibited by fenofibrate. Thus, fenofibrate affects prostate cancer cell invasion via an orchestrated action on versatile cancer cell properties determining this process. A novel mechanism of anti-invasive activity of fenofibrate, which depends on its interference with cell motility and the function of gap junctions regulated by reactive oxygen species, is suggested.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617875     DOI: 10.3892/or.2011.1321

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.

Authors:  Anna Wilk; Katarzyna Urbanska; Maja Grabacka; Jennifer Mullinax; Cezary Marcinkiewicz; David Impastato; John J Estrada; Krzysztof Reiss
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

Review 2.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

3.  Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.

Authors:  Anna Wilk; Dorota Wyczechowska; Adriana Zapata; Matthew Dean; Jennifer Mullinax; Luis Marrero; Christopher Parsons; Francesca Peruzzi; Frank Culicchia; Augusto Ochoa; Maja Grabacka; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

4.  Fenofibrate: direct attenuating effects on tumor growth.

Authors:  Shailendra Kapoor
Journal:  Radiat Oncol J       Date:  2013-03-31

5.  Anti-glioblastoma effects of phenolic variants of benzoylphenoxyacetamide (BPA) with high potential for blood brain barrier penetration.

Authors:  Joanna Stalinska; Cecilia Vittori; Charles H Ingraham Iv; Sean C Carson; Karlie Plaisance-Bonstaff; Adam Lassak; Celeste Faia; Susan B Colley; Francesca Peruzzi; Krzysztof Reiss; Branko S Jursic
Journal:  Sci Rep       Date:  2022-03-01       Impact factor: 4.379

6.  Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.

Authors:  Ting Li; Qunling Zhang; Jian Zhang; Gong Yang; Zhimin Shao; Jianmin Luo; Minhao Fan; Chen Ni; Zhenhua Wu; Xichun Hu
Journal:  BMC Cancer       Date:  2014-02-16       Impact factor: 4.430

Review 7.  Anticancer Properties of Fenofibrate: A Repurposing Use.

Authors:  Xin Lian; Gang Wang; Honglan Zhou; Zongyu Zheng; Yaowen Fu; Lu Cai
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

8.  Fenofibrate Interferes with the Diapedesis of Lung Adenocarcinoma Cells through the Interference with Cx43/EGF-Dependent Intercellular Signaling.

Authors:  Katarzyna Piwowarczyk; Edyta Kwiecień; Justyna Sośniak; Eliza Zimoląg; Emiliana Guzik; Jolanta Sroka; Zbigniew Madeja; Jarosław Czyż
Journal:  Cancers (Basel)       Date:  2018-09-28       Impact factor: 6.639

9.  Exploring anticancer activity of structurally modified benzylphenoxyacetamide (BPA); I: Synthesis strategies and computational analyses of substituted BPA variants with high anti-glioblastoma potential.

Authors:  Joanna Stalinska; Lisa Houser; Monika Rak; Susan B Colley; Krzysztof Reiss; Branko S Jursic
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

10.  CD44+ cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations.

Authors:  Tomasz Wróbel; Marcin Luty; Jessica Catapano; Elżbieta Karnas; Małgorzata Szczygieł; Katarzyna Piwowarczyk; Damian Ryszawy; Grażyna Drabik; Ewa Zuba-Surma; Maciej Siedlar; Zbigniew Madeja; Martyna Elas; Jarosław Czyż
Journal:  Stem Cells       Date:  2020-09-27       Impact factor: 6.277

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.